MDMA and PTSD

MDMA-assisted therapy shows remarkable promise, with studies indicating it can resolve symptoms in up to 71% of individuals with moderate to severe PTSD, far surpassing traditional treatments. The conversation highlights the limitations of conventional therapy and emphasizes the need for innovative approaches to trauma resolution. As MDMA approaches potential FDA approval, understanding its mechanisms and applications becomes crucial for those affected by trauma, including those with subthreshold PTSD.